Effect of Damask Rose extract in the prevention of ventilator-associated pneumonia

Clinical trial to compare the effect of damask rose extract and chlorhexidine in prevention of ventilator-associated pneumonia in critically ill patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201512115363N8

Enrollment

Registered

2016-12-04

Start date

2015-03-21

Completion date

Unknown

Last updated

2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventilator associated pneumonia. Pneumonia in bacterial diseases classified elsewhere

Interventions

Intervention 1: Intervention group 1: 10 ml Rose extract at a 0.5 percent concentration and 10 ml oral solution of chlorhexidine at a 0.12 percent will be given as a mouthwash three times a day. Inter

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Age between 20 to 50 years Admission less than 24 hours in intensive care unit Intubated patient Satisfaction of patients and patients' families

Exclusion criteria

Exclusion criteria: contraindications to any cause to enteral feeding pneumonia

Design outcomes

Primary

Measure	Time frame
Mortality. Timepoint: End of the study. Method of measurement: Records.;Ventilator associated pneumonia. Timepoint: Third day, Sixth day, Ninth day, twelfth day, fifteenth day. Method of measurement: Clinical Pulmonary Infection Score.	—

Secondary

Measure	Time frame
Length of intensive care unit stay. Timepoint: End of the study. Method of measurement: Records.;Connection to ventilator days. Timepoint: End of the study. Method of measurement: Records.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahsa Skandari

Zanjan University of Medical Sciences

Eskandari.m1990@gmail.com+98 21 4483 4648

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026